Gloria Pulliam

The management of oesophageal soft food bolus obstruction: a systematic review

Review of Food Bolus Management

Risk of oesophageal cancer in Barrett’s oesophagus and gastro-oesophageal reflux

Diagnostic and Therapeutic Use of Proton Pump Inhibitors in Non-Cardiac Chest Pain: A Metaanalysis

Foreign Bodies

Epidemiology of gastro-oesophageal reflux disease: a systematic review

Heartburn severity underestimates erosive esophagitis severity in elderly patients with gastroesophageal reflux disease

Measurement of pH Values in Human Tissues by Two‐Photon Microscopy

Oesophageal carcinoma

The Montreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based Consensus

Barrett's oesophagus

Systematic review: proton‐pump inhibitor failure in gastro‐oesophageal reflux disease – where next?

Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus

Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: Prevalence and clinical data

Serotonin, tryptophan metabolism and the brain-gut-microbiome axis

Characterization of bacterial biota in the distal esophagus of Japanese patients with reflux esophagitis and Barrett’s esophagus

Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus

Use of Glucagon in Relieving Esophageal Food Bolus Impaction in the Era of Eosinophilic Esophageal Infiltration

Glucagon for the Relief of Esophageal Food Impaction Does It Really Work?

Stress and the gastrointestinal tract

Assessment of the Predictors of Response to Glucagon in the Setting of Acute Esophageal Food Bolus Impaction

Burden of Gastrointestinal Disease in the United States: 2012 Update

International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding

Management of ingested foreign bodies and food impactions

SIDS and Other Sleep-Related Infant Deaths: Expansion of Recommendations for a Safe Infant Sleeping Environment

Removal and management of esophageal foreign bodies

Safety and efficacy of glucagon for the relief of acute esophageal food impaction

Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas

Pediatric Gastroesophageal Reflux Clinical Practice Guidelines

Global Epidemiology of Campylobacter Infection

Management of Ingested Foreign Bodies in Children

Canadian Consensus Conference on the Management of Gastroesophageal Reflux Disease in Adults – Update 2004

Evidence-Based Recommendations for Short- and Long-Term Management of Uninvestigated Dyspepsia in Primary Care: An Update of the Canadian Dyspepsia Working Group (CanDys) Clinical Management Tool

Removal of foreign bodies in the upper gastrointestinal tract in adults: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline

Design Strategies for Water-Soluble Small Molecular Chromogenic and Fluorogenic Probes

Correlation of oesophageal acid exposure with Barrett's oesophagus length

Effect of Doses of Glucagon Used to Treat Food Impaction on Esophageal Motor Function of Normal Subjects

Omeprazole 40 mg once a day is equally effective as lansoprazole 30 mg twice a day in symptom control of patients with gastro‐oesophageal reflux disease (GERD) who are resistant to conventional‐dose lansoprazole therapy—a prospective, randomized, multi‐centre study

Relationship between rate of change in acid exposure along the esophagus and length of Barrett's epithelium

The Value of Ambulatory 24 hr Esophageal pH Monitoring in Clinical Practice in Patients Who Were Referred with Persistent Gastroesophageal Reflux Disease (GERD)-Related Symptoms While on Standard Dose Anti-Reflux Medications

Reduced chemoreceptor sensitivity in patients with Barrett's esophagus may be related to age and not to the presence of Barrett's epithelium.

Effect of psychologically induced stress on symptom perception & autonomic nervous system response of patients (PTS.) With erosive esophagitis (EE) and non-erosive reflux disease (NERD)

Patients with non-cardiac chest pain (NCCP) recelving an empirical trial of high dose lansoprazole, demonstrate early symptom response. A double blind, placebo-controlled trial